London Daily

Focus on the big picture.
Tuesday, Jul 14, 2026

‘Ground zero of the opioid epidemic’: West Virginia puts drug giants on trial

‘Ground zero of the opioid epidemic’: West Virginia puts drug giants on trial

A series of federal cases over the pharmaceutical industry’s push to sell narcotic painkillers which created the worst drug epidemic in US history
The trial of the three biggest US drug distributors for illegally flooding West Virginia with hundreds of millions of prescription opioid pills, and driving the highest overdose rate in the country, is due to open on Monday.

The city of Huntington and surrounding Cabell county are suing McKesson, AmerisourceBergen and Cardinal Health, among the largest corporations in the US, as part of a series of federal cases over the pharmaceutical industry’s push to sell narcotic painkillers which created the worst drug epidemic in American history.

The two West Virginia local authorities accuse the distributors of turning Cabell county, with a population of just 90,000, into the “ground zero of the opioid epidemic sweeping the nation”, by flooding the area with nearly 100m opioid pills over a decade.

The lawsuit claims the companies put profit before lives by working in concert with “pill mill” doctors and pharmacists who were little better than drug dealers in supplying opioids to anyone who paid, in breach of laws requiring distributors to halt and report suspicious sales.

“The wholesale distributors have wholly ignored their legal obligations,” lawyers for Cabell county said.

“Instead of implementing controls to stop opioid abuse and alerting authorities to suspicious orders, the distributors have chosen to abuse their privileged position, lining their pockets by shipping massive quantities of drugs to distributors, pharmacies, and dispensaries without performing any checks – with devastating consequences to Americans.”

The companies say they were doing no more than delivering legal drugs to licensed pharmacies to fill prescriptions written by doctors.

If the trial goes ahead on Monday, it will be the first in a series of bellwether cases to establish whether opioid makers, distributors and pharmacy chains are liable to pay out billions of dollars to thousands of counties, cities and Native American tribes harmed by an epidemic that has caused more than 500,000 deaths since 1999 and blighted the lives of millions more.

In October 2019, McKesson and AmerisourceBergen were among four companies that agreed to pay $260m to settle another case hours before a trial was to begin in Ohio, threatening to expose what the distributors knew about illegal sales of the opioids they were delivering to fill prescriptions written by doctors and dispensed by pharmacists who have since been imprisoned.

In the West Virginia case, the distributors are seeking to prevent testimony by witnesses including West Virginia’s former chief health officer, Dr Rahul Gupta.

Defence lawyers want to block Gupta speaking about whether the pharmaceutical industry’s push to sell opioids led to overdose deaths, and whether addiction to prescription opioids drew people into using illegal narcotics such heroin and fentanyl which are not the main cause of overdoses.

The companies also do not want Gupta to speak about the epidemic’s impact on social issues such as the number of children taken into foster care.

Opioid distributors have paid out hundreds of millions of dollars to settle federal accusations that they failed to meet legal obligations to halt suspicious opioid deliveries, including McKesson which paid a record $150m fine in 2017.

Joseph Rannazzisi, a former senior Drug Enforcement Administration official who took action against the distributors, has called them “criminals” and said they “lack a conscience”.

The West Virginia lawsuit accuses the distributors of creating a “public nuisance”, a claim successfully used by Oklahoma against Johnson & Johnson over its push to sell opioids in the state using false claims about effectiveness and safety. A judge awarded the state $465m.

Drug distributors delivered 1.1bn opioid pills to West Virginia between 2006 and 2014, even as the state’s overdose rate rose to the highest in the US. Nearly 9m pills went to a single pharmacy in the small town of Kermit, with a population of 350, over just two years.

In 2018, the heads of the three drug distributors were lambasted at a congressional hearing by both Democrats and Republicans after denying their companies played any part in the opioid epidemic.

David McKinley, a Republican representing a West Virginia district, accused the CEOs of feeding the epidemic by riding roughshod over the law.

“None of you was complying with state law,” he said. “And yet you say, ‘We weren’t responsible.’ I think you were very much responsible.”

McKinley asked why, if doctors and pharmacists have gone to prison, drug distributor executives should not be jailed too.

“I just want you to feel shame about your roles, respectively, in all of this,” he said.
Newsletter

Related Articles

0:00
0:00
Close
UK Prime Minister Keir Starmer Offers Condolences Following Death of Qatar’s Father Amir
UK Regional Innovation Policy Focuses on Research Clusters Across Scotland, Wales, and Northern England
UK Corporate Transparency Rules Set to Become More Strict Under Modern Slavery Reform Plans
UK Civil Service Estate Strategy Shifts Government Activity Away From London
UK Strengthens National Security Powers Through New Threat Designations
Greater Manchester Police Conduct Drink and Drug Driving Operations After Football Events
UK Government Advances Darlington Economic Campus With Construction Milestone
UK Authorities Increase Football-Related Security Operations After Tournament Fixtures
UK Invests Fifty-One Million Pounds in National Cryogenics Facility and Regional Innovation Hubs
UK Moves Toward Tougher Modern Slavery Reporting Rules With Corporate Penalties
UK Government Reports Forty-Three Million Pounds in Savings From Office Estate Reform
UK Government Expands Civil Service Regional Strategy With Manchester and Darlington Campus Projects
UK Designates Iran’s Islamic Revolutionary Guard Corps as National Security Threat
United Kingdom Financial Markets Monitor Business Response to Economic Policy Changes
Scottish Renewable Energy Expansion Highlights Need for Faster Grid Development
Wales and Regions Strengthen Focus on Economic Development Through Tourism and Investment
Retail Industry Warns High Street Businesses Remain Under Pressure
Police Chiefs Highlight Growing Challenges Managing Protests and Public Order
Agriculture Leaders Seek Clarity on Post-Brexit Farming Support and Environmental Rules
Transport Unions Warn of Further Industrial Action Over Pay and Working Conditions
Welsh Tourism Sector Reports Strong Growth Driven by Domestic and International Visitors
National Infrastructure Review Gains Support as Leaders Seek Faster Project Delivery
Financial Markets Assess Impact of United Kingdom Corporate Tax Policy Changes
Northern Ireland Assembly Debates Cross-Border Trade and Infrastructure Cooperation Plans
Government Opens Consultations on Housing Reform and Planning System Changes
Scottish Government Faces Pressure to Accelerate Offshore Wind and Grid Expansion
National Energy System Operator Warns Grid Investment Is Needed for Future Electricity Demand Growth
United Kingdom Research Council Invests in Artificial Intelligence and Biotechnology Innovation Hubs
United Kingdom Expands Oversight of Skilled Worker Visa Sponsors Amid Migration Debate
Cross-Party MPs Call for National Infrastructure Strategy Review to Accelerate Economic Growth
Prime Minister Announces One Billion Pound NHS Funding Package Ahead of Winter Pressures
Bank of England Signals Cautious Approach to Interest Rates as Inflation Remains Above Forecasts
World Cup Visitors Turn American Big-Box Stores Into Souvenir Stops
Netflix Weighs Always-On Channels, Bundles and Short-Form Video
Passenger Is Pulled Partly Outside Ryanair Jet After Window Fails Mid-Flight
Innovation-led growth strategy
Public service reform pressure
Defence and industrial security
Labour leadership transition and economic reset
Northern England Pushes for Greater Influence in Britain’s Future Economic Model
UK Technology Strategy Focuses on Life Sciences, Digital Innovation and Research Investment
Britain and United States Maintain Focus on Pharmaceuticals Cooperation and Industrial Growth
UK Public Services Face Continued Pressure as Government Promises Visible Improvements
Regional Economic Power Becomes Key Theme in Britain’s Next Political Phase
Britain Expands Support for Small Businesses as Firms Seek Better Access to Finance
UK Economy Remains Central Political Challenge as Cost of Living and Growth Concerns Persist
National Health Service Introduces New Workplace Reviews to Improve Conditions for Healthcare Staff
UK Life Sciences Sector Secures More Than Three Billion Pounds in Investment to Support Innovation
Britain Strengthens Defence Strategy as Security Concerns Reshape Military and Industrial Policy
Andy Burnham Promises Stronger UK Defence Industry and Expanded Domestic Production
×